SCHEMBL2214558

SCHEMBL2214558

CCn1nc(C(C)C)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
GAA P10253 1/20 0.54
GRN P28799 5/20 0.39
SORT1 Q99523 5/20 0.39
MAPT P10636 2/20 0.38
HCAR3 P49019 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 2/20 0.37
APAF1 O14727 1/20 0.37
POLB P06746 1/20 0.37
GPR35 Q9HC97 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
TSHR P16473 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
PTGER1 P34995 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17076776 0.84 ALDH1A1 (0.41) ALDH1A1GAAMAPTLMNAAPAF1
SCHEMBL14398086 0.82 ALDH1A1 (0.51) ALDH1A1GAAGRNSORT1MAPT
SCHEMBL2215308 0.81 GRN (0.41) ALDH1A1GAAGRNSORT1MAPT
SCHEMBL25111008 0.81 BRD4 (0.40) ALDH1A1GAAMAPTNPC1LMNA
SCHEMBL17224836 0.80 ALDH1A1 (0.49) ALDH1A1GAAGRNSORT1NPC1
SCHEMBL710008 0.79 MAPT (0.56) ALDH1A1GAAGRNSORT1MAPT
SCHEMBL3572670 0.79 GRN (0.45) ALDH1A1GRNSORT1MAPTHCAR3
SCHEMBL3646146 0.79 MARS1 (0.46) ALDH1A1GAAGRNSORT1MAPT
SCHEMBL22151654 0.78 GRN (0.40) ALDH1A1GAAGRNSORT1MAPT
SCHEMBL570182 0.78 GRN (0.39) ALDH1A1GRNSORT1MAPTHCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8658635-B2 Benzpyrazol derivatives as inhibitors of PI3 kinases GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-02-25 US disclosed
EP-2300437-B1 BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES GLAXO GROUP LTD (GB) 2013-11-20 EP disclosed
US-20110178063-A1 BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES GLAXO GROUP LIMITED (GB) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178063-A1 BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES PIK3CA, PIK3CD, PI4KA ALDH1A1 1833/4885GAA 635/4885GRN 3705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.